StonvexLoading…
StonvexStonvexStonvexCore line items from TRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $57.61M | $41.16M | $38.32M | $15.09M |
Operating Income | $14.46M | $10.34M | $12.38M | $-1.89M |
Net Income | $6.57M | $3.51M | $7.04M | $-2.32M |
EPS (Diluted) | $0.00 | $0.00 | $0.01 | $-0.02 |
Total Assets | $117.25M | $98.86M | $84.20M | $71.84M |
Total Liabilities | $42.96M | $32.82M | $23.14M | $20.69M |
Cash & Equivalents | $7.77M | $8.33M | $7.63M | $8.48M |
Free Cash Flow OCF − CapEx | $3.49M | $2.06M | $1.40M | $-9.74M |
Shares Outstanding | Not available | Not available | Not available | Not available |